We are live on ! Find out more
CCM

Camber Capital Management Portfolio holdings

AUM $1.07B
1-Year Est. Return 8.19%
This Fund
S&P 500
This Quarter Est. Return
-9.29%
1 Year Est. Return
-8.19%
3 Year Est. Return
+26.6%
5 Year Est. Return
+54.57%
10 Year Est. Return
+164.72%
AUM
$1.92B
AUM Growth
-$354M
Cap. Flow
-$189M
Cap. Flow %
-9.84%
Top 10 Hldgs %
55.64%
Holding
47
New
10
Increased
8
Reduced
6
Closed
11

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$112M
2
MYGN icon
Myriad Genetics
MYGN
+$73.5M
3
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61M
4
BIIB icon
Biogen
BIIB
+$51.9M
5
ABT icon
Abbott
ABT
+$39.7M

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$75.5M
2
CYH icon
Community Health Systems
CYH
+$57.7M
3
THC icon
Tenet Healthcare
THC
+$56.6M
4
BHC icon
Bausch Health
BHC
+$31.2M
5
PTCT icon
PTC Therapeutics
PTCT
+$28M

Sector Composition

Rank Sector Weight
1 Healthcare 74.66%
2 Industrials 1.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELOS
26
DELISTED
Syneron Medical Ltd
ELOS
$19.7M 1.03%
2,347,593
– –
NVTA
27
DELISTED
Invitae Corporation
NVTA
$19M 0.99%
2,398,123
-43,999
-2% -$329K
CNC icon
28
Centene
CNC
$30.1B
$11.3M 0.59%
+400,000
New +$11.8M
OPCH icon
29
Option Care Health
OPCH
$3.36B
$10.6M 0.55%
2,545,000
– –
BIOL
30
DELISTED
Biolase, Inc.
BIOL
$7.46M 0.39%
+427
New +$8.45M
ARNA
31
DELISTED
Arena Pharmaceuticals Inc
ARNA
$6.04M 0.31%
425,000
-625,000
-60% -$9.68M
ATXS
32
DELISTED
Astria Therapeutics
ATXS
$3.61M 0.19%
16,667
– –
DXTR
33
DELISTED
Dextera Surgical Inc.
DXTR
$804K 0.04%
837,483
– –
BHC icon
34
Bausch Health
BHC
$2.25B
– –
-1,271,500
Closed -$31.2M
CYH icon
35
Community Health Systems
CYH
$391M
– –
-5,000,000
Closed -$57.7M
PLX icon
36
Protalix BioTherapeutics
PLX
$183M
– –
-1,327,500
Closed -$7.43M
PTCT icon
37
PTC Therapeutics
PTCT
$6.26B
– –
-2,000,000
Closed -$28M
SPY icon
38
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$784B
– –
-2,250,000
Closed -$487M
TEVA icon
39
CALL
Teva Pharmaceuticals
TEVA
$41.2B
– –
-2,000,000
Closed -$92M
THC icon
40
Tenet Healthcare
THC
$21.8B
– –
-2,500,000
Closed -$56.6M
MDCO
41
DELISTED
Medicines Co
MDCO
– –
-2,000,000
Closed -$75.5M
1
2

Similar funds

PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
NRD
Nebula Research & Development New York $1.17B AUM 15.19% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return
CCP
Camelot Capital Partners Laguna Beach, California $686M AUM 163.55% 1-Year Est. Return

Camber Capital Management's Q4 2016 Portfolio in Review

As of Q4 2016, Camber Capital Management held 47 positions worth $1.92B, down 16% from $2.27B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Camber Capital Management withdrew a net $189M in Q4 2016, closing 11 positions and reducing 6 holdings. Its most notable exit was Medicines Co, an estimated $75.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 75% of assets, up from 58% a quarter earlier, followed by Industrials.

Against the trend, Camber Capital Management opened a new position in Allergan plc worth $114M.

  • Camber Capital Management's largest Q4 2016 buy was Allergan plc: 543,000 shares worth $114M.
  • Camber Capital Management added most to Nektar Therapeutics in Q4 2016, an estimated $38M increase.
  • Camber Capital Management's biggest Q4 2016 reduction was Cardiovascular Systems, Inc., cutting an estimated $12.3M.
  • Camber Capital Management fully exited Medicines Co in Q4 2016, selling an estimated $75.5M.
  • Camber Capital Management's ten largest holdings make up 56% of its $1.92B portfolio in Q4 2016.
  • Camber Capital Management opened 10 new positions and closed 11 in Q4 2016.
  • Camber Capital Management's portfolio value fell 16% quarter-over-quarter to $1.92B.

Based on Camber Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.